Long-Term Outcome of Approved Pharmacotherapy for Diabetic Macular Edema: A Review of Randomized Controlled Trials in Fluocinolone Acetonide Implants, Dexamethasone Implants, Aflibercept and Ranibizumab
<p>Diabetic macular edema (DME) is a major sight-threatening cause in diabetic patients. The pathophysiology of macular edema involves both the presence of inflammation and angiogenic stimulant</p><p>regarding vascular endothelial growth factor (VEGF) [1]. Intravitreal injections o...
Wedi'i Gadw mewn:
Prif Awduron: | , |
---|---|
Fformat: | Llyfr |
Cyhoeddwyd: |
Journal of Clinical Research and Ophthalmology - Peertechz Publications,
2015-02-15.
|
Pynciau: | |
Mynediad Ar-lein: | Connect to this object online. |
Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
Rhyngrwyd
Connect to this object online.3rd Floor Main Library
Rhif Galw: |
A1234.567 |
---|---|
Copi 1 | Ar gael |